Olivier Rontes
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Olivier Rontes has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Clement Chassery
Department of Anesthesiology, Clinique Medipole Garonne, Toulouse, France
3 shared publications - Philippe Marty
Department of Anesthesiology, Clinique Medipole Garonne, Toulouse, France
3 shared publications Anne De Lussy
Department of Anesthesiology, Clinique Medipole Garonne, Toulouse, France
2 shared publicationsBertrand Basset
Department of Anesthesiology, Clinique Medipole Garonne, Toulouse, France
2 shared publicationsCecile Naudin
Clinical Research Department, Ambroise Pare Hospital Group, Neuilly-sur-Seine, France
2 shared publicationsCorine Vuillaume
Department of Anesthesiology, Clinique Medipole Garonne, Toulouse, France
2 shared publications
Latest Publications
- 23 January 2026
- Published by BMJ in Regional Anesthesia & Pain Medicine
WARLANT: Wide Awake Regional or Local Anesthesia No Tourniquet
- 23 January 2026
- Published by BMJ in Regional Anesthesia & Pain Medicine
WARLANT: Wide Awake Regional or Local Anesthesia No Tourniquet
- 13 November 2025
- Published by BMJ in Regional Anesthesia & Pain Medicine
Wide awake local anesthesia no tourniquet (WALANT) versus ultrasound-guided axillary block in carpal tunnel release: a non-inferiority randomized controlled trial
Background and objectives Ultrasound-guided axillary block (USGAB) is currently an accepted anesthesia technique for surgery of the hand, wrist or elbow. Recently, a new strategy for upper extremity surgery has emerged—Wide-Awake Local Anesthesia, No Tourniquet (WALANT). This prospective, randomized, single-center, double-blind, non-inferiority trial compared WALANT versus USGAB to provide surgical anesthesia in outpatient endoscopic carpal tunnel release (CTR). Methods Patients undergoing endoscopic CTR (n=130) were randomly allocated to WALANT or USGAB using lidocaine. The primary outcome was the success rate of WALANT versus USGAB in providing surgical anesthesia. A successful block was defined as adequate anesthesia for surgery without the need for supplementation. Results The proportion of subjects who achieved a successful block was 89% in the USGAB group versus 100% in the WALANT group. Non-inferiority of WALANT with respect to USGAB was confirmed (pConclusions For outpatient endoscopic CTR, the success rate of WALANT technique is non-inferior to USGAB. Trial registration number NCT06040840.
- 13 November 2025
- Published by BMJ in Regional Anesthesia & Pain Medicine
Wide awake local anesthesia no tourniquet (WALANT) versus ultrasound-guided axillary block in carpal tunnel release: a non-inferiority randomized controlled trial
Background and objectives Ultrasound-guided axillary block (USGAB) is currently an accepted anesthesia technique for surgery of the hand, wrist or elbow. Recently, a new strategy for upper extremity surgery has emerged—Wide-Awake Local Anesthesia, No Tourniquet (WALANT). This prospective, randomized, single-center, double-blind, non-inferiority trial compared WALANT versus USGAB to provide surgical anesthesia in outpatient endoscopic carpal tunnel release (CTR). Methods Patients undergoing endoscopic CTR (n=130) were randomly allocated to WALANT or USGAB using lidocaine. The primary outcome was the success rate of WALANT versus USGAB in providing surgical anesthesia. A successful block was defined as adequate anesthesia for surgery without the need for supplementation. Results The proportion of subjects who achieved a successful block was 89% in the USGAB group versus 100% in the WALANT group. Non-inferiority of WALANT with respect to USGAB was confirmed (pConclusions For outpatient endoscopic CTR, the success rate of WALANT technique is non-inferior to USGAB. Trial registration number NCT06040840.
- Top Cited Papers
- 2 December 2023
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 132 (2) , 352-358
Opioid-free versus opioid-sparing anaesthesia in ambulatory total hip arthroplasty: a randomised controlled trial
- 2 December 2023
- Published by Elsevier in British Journal of Anaesthesia
- Vol. 132 (2) , 352-358
Top Cited PapersOpioid-free versus opioid-sparing anaesthesia in ambulatory total hip arthroplasty: a randomised controlled trial
- 21 October 2020
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 46 (2) , 104-110
Total knee arthroplasty under quadruple nerve block with ropivacaine 0.32%: effect of addition of intravenous dexmedetomidine to intravenous dexamethasone on analgesic duration
Background and objectives Peripheral nerve blocks reduce postoperative pain and enhance recovery after total knee arthroplasty (TKA). This study aims to assess the benefits of addition of intravenous dexmedetomidine (DexM) to intravenous dexamethasone on the analgesic duration of quadruple nerve blocks. Methods This double-blind, randomized, controlled trial prospectively enrolled 90 patients scheduled for TKA under quadruple nerve blocks (sciatic, femoral, obturator, and lateral femoral cutaneous nerves blocks) with 70 mL, 0.32% ropivacaine. All patients received systemic dexamethasone 10 mg. Patients were randomized to receive DexM (2 µg/kg, intravenous) or placebo (1:1 ratio). The primary endpoint was the duration of analgesia defined as the time to first request for rescue analgesia (oxycodone). Results Kaplan-Meier curves for the first analgesic request were similar between groups (log-rank test; p=0.27). Median (IQR) duration of analgesia was similar between placebo (1575 min (1211–1952)) and DexM (1470 min (1263–1700)) groups (p=0.56). Cumulative consumption of oxycodone at the 48th hour was 20 mg (10–30) and 30 mg (20–40) in placebo and DexM groups, respectively (p=0.14). The day after surgery, 93% and 89% of patients were able to walk in placebo and DexM groups, respectively (p=0.46). Intravenous DexM was associated with bradycardia, hypotension and longer recovery room stay (pConclusions In a multimodal analgesic regimen, addition of systemic DexM (2 µg/kg) to systemic dexamethasone does not prolong the analgesic duration of quadruple nerve block with ropivacaine 0.32% after TKA. Trial registration number NCT03834129.
- 21 October 2020
- Published by BMJ in Regional Anesthesia & Pain Medicine
- Vol. 46 (2) , 104-110
Total knee arthroplasty under quadruple nerve block with ropivacaine 0.32%: effect of addition of intravenous dexmedetomidine to intravenous dexamethasone on analgesic duration
Background and objectives Peripheral nerve blocks reduce postoperative pain and enhance recovery after total knee arthroplasty (TKA). This study aims to assess the benefits of addition of intravenous dexmedetomidine (DexM) to intravenous dexamethasone on the analgesic duration of quadruple nerve blocks. Methods This double-blind, randomized, controlled trial prospectively enrolled 90 patients scheduled for TKA under quadruple nerve blocks (sciatic, femoral, obturator, and lateral femoral cutaneous nerves blocks) with 70 mL, 0.32% ropivacaine. All patients received systemic dexamethasone 10 mg. Patients were randomized to receive DexM (2 µg/kg, intravenous) or placebo (1:1 ratio). The primary endpoint was the duration of analgesia defined as the time to first request for rescue analgesia (oxycodone). Results Kaplan-Meier curves for the first analgesic request were similar between groups (log-rank test; p=0.27). Median (IQR) duration of analgesia was similar between placebo (1575 min (1211–1952)) and DexM (1470 min (1263–1700)) groups (p=0.56). Cumulative consumption of oxycodone at the 48th hour was 20 mg (10–30) and 30 mg (20–40) in placebo and DexM groups, respectively (p=0.14). The day after surgery, 93% and 89% of patients were able to walk in placebo and DexM groups, respectively (p=0.46). Intravenous DexM was associated with bradycardia, hypotension and longer recovery room stay (pConclusions In a multimodal analgesic regimen, addition of systemic DexM (2 µg/kg) to systemic dexamethasone does not prolong the analgesic duration of quadruple nerve block with ropivacaine 0.32% after TKA. Trial registration number NCT03834129.
- 1 July 2012
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 31 (7-8) , 644-645
Hypnose et bloc paravertébral échoguidé dans la chirurgie du cancer du sein
- 1 July 2012
- Published by Elsevier in Annales Françaises d'Anesthésie et de Réanimation
- Vol. 31 (7-8) , 644-645
Hypnose et bloc paravertébral échoguidé dans la chirurgie du cancer du sein